GSK plc (GSK)

CIK 0001131399 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
—
Audit Information
—
Statements
Consolidated Income Statement
—
Consolidated Statement of Comprehensive Income
—
Consolidated Balance Sheet
—
Consolidated Statement of Changes In Equity
—
Consolidated Cash Flow Statement
—
Notes
Accounting Principles and Policies
—
Acquisitions and Disposals
—
Adjustments Reconciling Profit After Tax To Operating Cash Flows
—
Adjustments Reconciling Total Profit After Tax To Operating Cash Flows
—
Assets and Liabilities Held For Sale
—
Assets Held For Sale
—
Associates and Joint Ventures
—
Cash and Cash Equivalents
—
Commitments
—
Contingent Consideration Liabilities
—
Contingent Liabilities
—
Critical Accounting Judgements and Key Sources of Estimation Uncertainty
—
Current Equity Investments
—
Cybersecurity Risk Management and Strategy Disclosure
—
Dividends
—
Earnings Per Share
—
Employee Costs
—
Employee Share Schemes
—
Exchange Rates
—
Finance Expense
—
Finance Income
—
Financial Instruments and Related Disclosures
—
Goodwill
—
Insider Trading Policies and Procedures
—
Inventories
—
Investments In Associates and Joint Ventures
—
Legal Proceedings
—
Major Restructuring Costs
—
Movements In Equity
—
Net Debt
—
New Accounting Requirements
—
Non-controlling Interests
—
Operating Profit
—
Other Intangible Assets
—
Other Investments
—
Other Non-current Assets
—
Other Non-current Liabilities
—
Other Operating Income/(expense)
—
Other Provisions
—
Pensions and Other Post-employment Benefits
—
Post Balance Sheet Events
—
Presentation of The Financial Statements
—
Principal Group Companies
—
Property, Plant and Equipment
—
Reconciliation of Net Cash Flow To Movement In Net Debt
—
Related Party Transactions
—
Right of Use Assets
—
Share Capital and Share Premium Account
—
Taxation
—
Trade and Other Payables
—
Trade and Other Receivables
—
Turnover and Segment Information
—